Summary

Pre-Filled Syringes Market, By Type (Conventional, Safety), By Material (Glass, Plastic, Stainless Steel, Elastomer), By Design (Single-chamber, Dual-chamber, Customized), By Delivery (Intravenous, Subcutaneous, Intramuscular, Others), By Application (Diabetes, Rheumatoid Arthritis, Anaphylaxis, Others) Global Market Size, Segmental analysis, Regional Overview, Company shares analysis, Leading Company Profiles and Market Forecast, 2025 ? 2035
The Pre-Filled Syringes Market accounted for USD 8.85 Billion in 2024 and is expected to reach USD 26.0 Billion by 2035, growing at a CAGR of around 10.3% between 2025 and 2035. The Prefilled Syringes Market relates to an industry that focuses on the manufacture and distribution of syringes prefilled with specified doses of medication, ready for immediate application onto the patient. These syringes, said in literature to enhance patient safety, reduce medication errors, and increase ease of handling, are particularly pertinent for chronic disease management and vaccine delivery. Self-administerable therapies introduced into the market are a wake-up call, whereas biologics have taken center stage. The format, in this case, is the best one for drug delivery with minimal contamination risk, and pharmaceutical companies tend to regard it. Under the ongoing transition of healthcare-based home care and customized treatment, prefilled syringes serve the purpose of getting along with those models. Innovation in materials, smart features, and sustainability in design truly will carve the path forward for this sector. The general market outlook is auspicious and healthy due to technological advances, growing healthcare demands, and trends toward global adoption.
Advances in Biologics and Biopharmaceuticals
The entire pharmaceutical front is rapidly turning toward biologics, which in most cases require parenteral administration because of their molecular complexities. Pre-filled syringes are ideal for the administration of such drugs since they offer good stability and ease of delivery. Meanwhile, as biopharmaceutical companies continue to innovate, the sector is very dynamic, with increased usage requirements of these delivery formats that are considered sterile, ready-to-use, and compatible. All of these features minimize preparation time and guarantee product integrity, which is important for sensitive biologic compounds. Moreover, regulatory bodies advocate for such drugs to have safe and effective delivery systems as a reason for this increased demand. This phenomenon is further reinforced by the growth of biologics with technological improvements in syringe design. Manufacturers are therefore meeting these demands in the form of specialized formats such as dual-chamber and auto-injector-compatible syringes. This growth symbiosis is building a solid future for prefilled syringes.
Concerns About Material Compatibility
Compatibility between drug formulations and syringe materials is a most crucial factor towards the overall stability and safety of a product. Sometimes, biologics or vaccines are not compatible with certain glass types or rubber components, and this results in potency loss or contamination. Appropriate material selection for the manufacturing of prefilled syringes thus becomes a very challenging requirement. Migrating leachables or extractables into drug formulation also generates concerns about patient safety. Such circumstances often end up in recalls or delays in the approval process by the regulatory agencies. The very extensive compatibility evaluation requirements elongated the timeframe for product development and increased costs. While some solutions, like polymer syringes, may solve some problems, they cause their problems. Hence, optimal compatibility is a major restraint for the expansion of the market.
Growth in New Developments
Healthcare infrastructure and awareness among patients are developing at a very high speed in emerging economies. The high urbanization and increased healthcare fund allocations make these markets very likely for prefilled syringes. Investment by governments is also seen in vaccination programs and chronic disease management, giving them put demand for usage. International pharmaceutical firms are stepping into these regions through partnerships and local manufacturing. Inexpensive prefilled syringes specifically designed for price-sensitive markets have considerable growth potential. Patients in these areas are now increasingly inclined towards seeking treatment that is more convenient and light on the pockets, with claimed safety. The developing regulatory frameworks locally are making access to such markets easier. The combination of unmet medical needs and increasing healthcare accessibility offers strong opportunities for growth on a long-term basis.
Segment Analysis
Glass used to be the major material utilized in the pre-filled syringe-making market because of its good chemical resistance capacities and high transparency, and compatibility with most drugs. Thus, glass is still the most preferred material for high-value biologics and vaccines. However, that gap is being reduced by plastics and high-use cycles like those made by cyclic olefin polymers, which then provide sound mechanical safety and can be designed with freedom. They find more importance in auto-injectors and smart syringes, where risks of breakage and patented manufacturing are managed well. Innovative solutions for features focusing on the user can also be achieved with plastic: ergonomic shapes of devices that incorporate advanced delivery mechanisms will continue to be developed. Material selection is increasingly guided by compatibility, cost, and usability.
Syringes need pre-filled insulin syringes to ensure correct and convenient administration, such as in diabetes management. The same prefilled needles allow cancer patients to administer their chemotherapeutic agents and supportive medicines that help reduce hospital stays. A lot of treatments for rheumatoid arthritis use biomedicals that require consistent self-administered injections, which would recommend the use of pre-filled syringes. Anticoagulants, vaccines, hormone treatments, and other types of medications usually fall under emergency therapeutics in which speed and accuracy are factors. Each of these therapy fields has a distinct requirement for the configuration of, for example, dosage control, safety mechanisms, or storage stability. The wide application range thus further emphasizes the versatility of pre-filled syringes. But as long as new therapies come out, especially injectables, the graduated application foundation for these syringes continuously expands with time.
Regional Analysis
Asia Pacific witnesses a fast-paced regional propensity for growth in the pre-filled syringes market owing to the deepening healthcare infrastructures and increasing disease burdens. Countries such as China, India, and Japan are investing heavily in the modernization of healthcare. The region has a huge population of patients with access to healthcare, and hence, promising future opportunities. The operations base of pharmaceutical companies is focused on this region to manufacture and distribute, using reduced operational costs. Other avenues that guarantee increased demand for syringes are vaccination and health campaigns by the governments. Local companies are emerging as key players in the generic biologics market and drug delivery systems. Thus, Asia Pacific, with this vibrant transformation of health, would be turning into an engine of growth in the future.
Competitive landscape
The Prefilled Syringes Market bustles with both the world's big pharmaceutical companies and some specialized players making medical devices. Innovation, particularly concerning the materials used in syringes, their safety features, and digital connectivity, marks the focus of such companies at present. Mergers and acquisitions, now common as firms aim to broaden their portfolios and reach new markets, are fast becoming the path for strategic collaborations. The leaders have placed very heavy investments in R&D, focusing on better understanding the needs of users and complying with regulations to produce products easily and meet regulations. They are also increasing customizations and co-developments of patents with pharma companies, especially for biologics. There is increasing competition from new entrants who are coming up with economically viable solutions, especially in some emerging markets. Increasingly, ease of use, patient comfort, and smart delivery features are being used to differentiate between markets. The face of competitiveness is changing with a very strong focus on technological advancement and global expansion.
Report Coverage:
By Type
- Conventional
- Safety
By Material
- Glass
- Plastic
- Stainless Steel
- Elastomer
By Design
- Single-chamber
- Dual-chamber
- Customized
By Delivery
- Intravenous
- Subcutaneous
- Intramuscular
- Others
By Application
- Diabetes
- Rheumatoid Arthritis
- Anaphylaxis
- Others

ページTOPに戻る

Table of Contents

Table of Contents
1. Methodology & Report Coverage
1.1. Definition & Objective
1.2. Market Evaluation & forecast parameter
1.3. Research Methodology
1.4. Data Validation Sources
1.4.1. Secondary Research
1.4.2. Primary Research
2. Market Overview
3. Pre-Filled Syringes Market : Market Dynamics
3.1. Executive Summary
3.2. Market Driving Factors
3.2.1. Increasing prevalence of chronic diseases necessitates advanced drug delivery systems.
3.2.2. Rising demand for self-administration and home healthcare options boosts the market.
3.2.3. Technological advancements in syringe design enhance safety and usability.
3.3. Key Industry Pitfalls & Challenges
3.3.1. Stringent regulatory approvals and compliance requirements.
3.3.2. High manufacturing costs and technical complexities.
3.3.3. Limited availability of skilled professionals and specialized equipment.
3.4. Market Opportunities
3.4.1. Advancements in syringe materials and technologies offer opportunities for innovation.
3.4.2. Expanding vaccination programs increase the demand for pre-filled syringes.
3.4.3. Emerging markets present opportunities for growth due to improving healthcare infrastructure.
3.5. Porter’s Five Forces Analysis
3.6. PESTLE Analysis
3.7. Regulatory landscape
3.8. Pipeline Analysis
3.9. ESG Scenario
3.10. Competitive landscape
3.10.1. Company Market Share
3.10.2. Market Positioning
3.10.3. Strategy framework
3.10.4. Recent Acquisitions & Mergers
4. Pre-Filled Syringes Market, By Type Segment Analysis
4.1. Overview Dynamics
4.1.1. Market Revenue Share, By Type, 2025 & 2035
4.1.2. Key Market Trends, Growth Factors, & Opportunities
4.2. Conventional
4.2.1. Market Revenue Share, By Type, 2025 & 2035
4.3. Safety
4.3.1. Market Revenue Share, By Type, 2025 & 2035
5. Pre-Filled Syringes Market, By Material Segment Analysis
5.1. Overview
5.1.1. Market Revenue Share, By Material, 2025 & 2035
5.1.2. Key Market Trends, Growth Factors, & Opportunities
5.2. Glass
5.2.1. Market Size and Forecast, By Material 2025-2035 (USD Million)
5.3. Plastic
5.3.1. Market Size and Forecast, By Material 2025-2035 (USD Million)
5.4. Stainless Steel
5.4.1. Market Size and Forecast, By Material 2025-2035 (USD Million)
5.5. Elastomer
5.5.1. Market Size and Forecast, By Material 2025-2035 (USD Million)
6. Pre-Filled Syringes Market, By Design Segment Analysis
6.1. Overview
6.1.1. Market Revenue Share, By Design, 2025 & 2035
6.1.2. Key Market Trends, Growth Factors, & Opportunities
6.2. Single-chamber
6.2.1. Market Size and Forecast, By Design 2025-2035 (USD Million)
6.3. Dual-chamber
6.3.1. Market Size and Forecast, By Design 2025-2035 (USD Million)
6.4. Customized
6.4.1. Market Size and Forecast, By Design 2025-2035 (USD Million)
7. Pre-Filled Syringes Market, By Delivery Segment Analysis
7.1. Overview
7.1.1. Market Revenue Share, By Delivery, 2025 & 2035
7.1.2. Key Market Trends, Growth Factors, & Opportunities
7.2. Intravenous
7.2.1. Market Size and Forecast, By Delivery 2025-2035 (USD Million)
7.3. Subcutaneous
7.3.1. Market Size and Forecast, By Delivery 2025-2035 (USD Million)
7.4. Intramuscular
7.4.1. Market Size and Forecast, By Delivery 2025-2035 (USD Million)
7.5. Others
7.5.1. Market Size and Forecast, By Delivery 2025-2035 (USD Million)
8. Pre-Filled Syringes Market, By Application Segment Analysis
8.1. Overview
8.1.1. Market Revenue Share, By Application, 2025 & 2035
8.1.2. Key Market Trends, Growth Factors, & Opportunities
8.2. Diabetes
8.2.1. Market Size and Forecast, By Application 2025-2035 (USD Million)
8.3. Rheumatoid Arthritis
8.3.1. Market Size and Forecast, By Application 2025-2035 (USD Million)
8.4. Anaphylaxis
8.4.1. Market Size and Forecast, By Application 2025-2035 (USD Million)
8.5. Others
8.5.1. Market Size and Forecast, By Application 2025-2035 (USD Million)
9. Pre-Filled Syringes Market, Region Segment Analysis
9.1. Overview
9.1.1. Global Market Revenue Share, By Region, 2025 & 2035
9.1.2. Global Market Revenue, By Region, 2025-2035 (USD Million)
9.2. North America
9.2.1. North America Market Revenue, By Type, 2025-2035 (USD Million)
9.2.2. North America Market Revenue, By Material, 2025-2035
9.2.3. North America Market Revenue, By Design, 2025-2035
9.2.4. North America Market Revenue, By Delivery, 2025-2035
9.2.5. North America Market Revenue, By Application, 2025-2035
9.2.6. North America Market Revenue, By Region, 2025-2035
9.2.7. U.S.
9.2.7.1. U.S. Market Revenue, By Type , 2025-2035 (USD Million)
9.2.7.2. U.S. Market Revenue, By Material, 2025-2035
9.2.7.3. U.S. Market Revenue, By Design, 2025-2035
9.2.7.4. U.S. Market Revenue, By Delivery, 2025-2035
9.2.7.5. U.S. Market Revenue, By Application, 2025-2035
9.2.7.6. U.S. Market Revenue, By Region, 2025-2035
9.2.8. Canada
9.2.8.1. Canada Market Revenue, By Type , 2025-2035 (USD Million)
9.2.8.2. Canada Market Revenue, By Material, 2025-2035
9.2.8.3. Canada Market Revenue, By Design, 2025-2035
9.2.8.4. Canada Market Revenue, By Delivery, 2025-2035
9.2.8.5. Canada Market Revenue, By Application, 2025-2035
9.2.8.6. Canada Market Revenue, By Region, 2025-2035
9.3. Europe
9.3.1. Europe Market Revenue, By Type , 2025-2035 (USD Million)
9.3.2. Europe Market Revenue, By Material, 2025-2035
9.3.3. Europe Market Revenue, By Design, 2025-2035
9.3.4. Europe Market Revenue, By Delivery, 2025-2035
9.3.5. Europe Market Revenue, By Application, 2025-2035
9.3.6. Europe Market Revenue, By Region, 2025-2035
9.3.7. Germany
9.3.7.1. Germany Market Revenue, By Type , 2025-2035 (USD Million)
9.3.7.2. Germany Market Revenue, By Material, 2025-2035
9.3.7.3. Germany Market Revenue, By Design, 2025-2035
9.3.7.4. Germany Market Revenue, By Delivery, 2025-2035
9.3.7.5. Germany Market Revenue, By Application, 2025-2035
9.3.7.6. Germany Market Revenue, By Region, 2025-2035
9.3.8. France
9.3.8.1. France Market Revenue, By Type , 2025-2035 (USD Million)
9.3.8.2. France Market Revenue, By Material, 2025-2035
9.3.8.3. France Market Revenue, By Design, 2025-2035
9.3.8.4. France Market Revenue, By Delivery, 2025-2035
9.3.8.5. France Market Revenue, By Application, 2025-2035
9.3.8.6. France Market Revenue, By Region, 2025-2035
9.3.9. U.K.
9.3.9.1. U.K. Market Revenue, By Type , 2025-2035 (USD Million)
9.3.9.2. U.K. Market Revenue, By Material, 2025-2035
9.3.9.3. U.K. Market Revenue, By Design, 2025-2035
9.3.9.4. U.K. Market Revenue, By Delivery, 2025-2035
9.3.9.5. U.K. Market Revenue, By Application, 2025-2035
9.3.9.6. U.K. Market Revenue, By Region, 2025-2035
9.3.10. Italy
9.3.10.1. Italy Market Revenue, By Type , 2025-2035 (USD Million)
9.3.10.2. Italy Market Revenue, By Material, 2025-2035
9.3.10.3. Italy Market Revenue, By Design, 2025-2035
9.3.10.4. Italy Market Revenue, By Delivery, 2025-2035
9.3.10.5. Italy Market Revenue, By Application, 2025-2035
9.3.10.6. Italy Market Revenue, By Region, 2025-2035
9.3.11. Spain
9.3.11.1. Spain Market Revenue, By Type , 2025-2035 (USD Million)
9.3.11.2. Spain Market Revenue, By Material, 2025-2035
9.3.11.3. Spain Market Revenue, By Design, 2025-2035
9.3.11.4. Spain Market Revenue, By Delivery, 2025-2035
9.3.11.5. Spain Market Revenue, By Application, 2025-2035
9.3.11.6. Spain Market Revenue, By Region, 2025-2035
9.3.12. Rest of Europe
9.3.12.1. Rest of Europe Market Revenue, By Type , 2025-2035 (USD Million)
9.3.12.2. Rest of Europe Market Revenue, By Material, 2025-2035
9.3.12.3. Rest of Europe Market Revenue, By Design, 2025-2035
9.3.12.4. Rest of Europe Market Revenue, By Delivery, 2025-2035
9.3.12.5. Rest of Europe Market Revenue, By Application, 2025-2035
9.3.12.6. Rest of Europe Market Revenue, By Region, 2025-2035
9.4. Asia Pacific
9.4.1. Asia Pacific Market Revenue, By Type , 2025-2035 (USD Million)
9.4.2. Asia Pacific Market Revenue, By Material, 2025-2035
9.4.3. Asia Pacific Market Revenue, By Design, 2025-2035
9.4.4. Asia Pacific Market Revenue, By Delivery, 2025-2035
9.4.5. Asia Pacific Market Revenue, By Application, 2025-2035
9.4.6. Asia Pacific Market Revenue, By Region, 2025-2035
9.4.7. China
9.4.7.1. China Market Revenue, By Type , 2025-2035 (USD Million)
9.4.7.2. China Market Revenue, By Material, 2025-2035
9.4.7.3. China Market Revenue, By Design, 2025-2035
9.4.7.4. China Market Revenue, By Delivery, 2025-2035
9.4.7.5. China Market Revenue, By Application, 2025-2035
9.4.7.6. China Market Revenue, By Region, 2025-2035
9.4.8. Japan
9.4.8.1. Japan Market Revenue, By Type , 2025-2035 (USD Million)
9.4.8.2. Japan Market Revenue, By Material, 2025-2035
9.4.8.3. Japan Market Revenue, By Design, 2025-2035
9.4.8.4. Japan Market Revenue, By Delivery, 2025-2035
9.4.8.5. Japan Market Revenue, By Application, 2025-2035
9.4.8.6. Japan Market Revenue, By Region, 2025-2035
9.4.9. India
9.4.9.1. India Market Revenue, By Type , 2025-2035 (USD Million)
9.4.9.2. India Market Revenue, By Material, 2025-2035
9.4.9.3. India Market Revenue, By Design, 2025-2035
9.4.9.4. India Market Revenue, By Delivery, 2025-2035
9.4.9.5. India Market Revenue, By Application, 2025-2035
9.4.9.6. India Market Revenue, By Region, 2025-2035
9.4.10. Australia
9.4.10.1. Australia Market Revenue, By Type , 2025-2035 (USD Million)
9.4.10.2. Australia Market Revenue, By Material, 2025-2035
9.4.10.3. Australia Market Revenue, By Design, 2025-2035
9.4.10.4. Australia Market Revenue, By Delivery, 2025-2035
9.4.10.5. Australia Market Revenue, By Application, 2025-2035
9.4.10.6. Australia Market Revenue, By Region, 2025-2035
9.4.11. South Korea
9.4.11.1. South Korea Market Revenue, By Type , 2025-2035 (USD Million)
9.4.11.2. South Korea Market Revenue, By Material, 2025-2035
9.4.11.3. South Korea Market Revenue, By Design, 2025-2035
9.4.11.4. South Korea Market Revenue, By Delivery, 2025-2035
9.4.11.5. South Korea Market Revenue, By Application, 2025-2035
9.4.11.6. South Korea Market Revenue, By Region, 2025-2035
9.4.12. Singapore
9.4.12.1. Singapore Market Revenue, By Type , 2025-2035 (USD Million)
9.4.12.2. Singapore Market Revenue, By Material, 2025-2035
9.4.12.3. Singapore Market Revenue, By Design, 2025-2035
9.4.12.4. Singapore Market Revenue, By Delivery, 2025-2035
9.4.12.5. Singapore Market Revenue, By Application, 2025-2035
9.4.12.6. Singapore Market Revenue, By Region, 2025-2035
9.4.13. Rest of Asia Pacific
9.4.13.1. Rest of Asia Pacific Market Revenue, By Type , 2025-2035 (USD Million)
9.4.13.2. Rest of Asia Pacific Market Revenue, By Material, 2025-2035
9.4.13.3. Rest of Asia Pacific Market Revenue, By Design, 2025-2035
9.4.13.4. Rest of Asia Pacific Market Revenue, By Delivery, 2025-2035
9.4.13.5. Rest of Asia Pacific Market Revenue, By Application, 2025-2035
9.4.13.6. Rest of Asia Pacific Market Revenue, By Region, 2025-2035
9.5. Latin America
9.5.1. Latin America Market Revenue, By Type , 2025-2035 (USD Million)
9.5.2. Latin America Market Revenue, By Material, 2025-2035
9.5.3. Latin America Market Revenue, By Design, 2025-2035
9.5.4. Latin America Market Revenue, By Delivery, 2025-2035
9.5.5. Latin America Market Revenue, By Application, 2025-2035
9.5.6. Latin America Market Revenue, By Region, 2025-2035
9.5.7. Brazil
9.5.7.1. Brazil Market Revenue, By Type , 2025-2035 (USD Million)
9.5.7.2. Brazil Market Revenue, By Material, 2025-2035
9.5.7.3. Brazil Market Revenue, By Design, 2025-2035
9.5.7.4. Brazil Market Revenue, By Delivery, 2025-2035
9.5.7.5. Brazil Market Revenue, By Application, 2025-2035
9.5.7.6. Brazil Market Revenue, By Region, 2025-2035
9.5.8. Mexico
9.5.8.1. Mexico Market Revenue, By Type , 2025-2035 (USD Million)
9.5.8.2. Mexico Market Revenue, By Material, 2025-2035
9.5.8.3. Mexico Market Revenue, By Design, 2025-2035
9.5.8.4. Mexico Market Revenue, By Delivery, 2025-2035
9.5.8.5. Mexico Market Revenue, By Application, 2025-2035
9.5.8.6. Mexico Market Revenue, By Region, 2025-2035
9.5.9. Argentina
9.5.9.1. Argentina Market Revenue, By Type , 2025-2035 (USD Million)
9.5.9.2. Argentina Market Revenue, By Material, 2025-2035
9.5.9.3. Argentina Market Revenue, By Design, 2025-2035
9.5.9.4. Argentina Market Revenue, By Delivery, 2025-2035
9.5.9.5. Argentina Market Revenue, By Application, 2025-2035
9.5.9.6. Argentina Market Revenue, By Region, 2025-2035
9.5.10. Rest of Latin America
9.5.10.1. Rest of Latin America Market Revenue, By Type , 2025-2035 (USD Million)
9.5.10.2. Rest of Latin America Market Revenue, By Material, 2025-2035
9.5.10.3. Rest of Latin America Market Revenue, By Design, 2025-2035
9.5.10.4. Rest of Latin America Market Revenue, By Delivery, 2025-2035
9.5.10.5. Rest of Latin America Market Revenue, By Application, 2025-2035
9.5.10.6. Rest of Latin America Market Revenue, By Region, 2025-2035
9.6. MEA
9.6.1. MEA Market Revenue, By Type , 2025-2035 (USD Million)
9.6.2. MEA Market Revenue, By Material, 2025-2035
9.6.3. MEA Market Revenue, By Design, 2025-2035
9.6.4. MEA Market Revenue, By Delivery, 2025-2035
9.6.5. MEA Market Revenue, By Application, 2025-2035
9.6.6. MEA Market Revenue, By Region, 2025-2035
9.6.7. GCC
9.6.7.1. GCC Market Revenue, By Type , 2025-2035 (USD Million)
9.6.7.2. GCC Market Revenue, By Material, 2025-2035
9.6.7.3. GCC Market Revenue, By Design, 2025-2035
9.6.7.4. GCC Market Revenue, By Delivery, 2025-2035
9.6.7.5. GCC Market Revenue, By Application, 2025-2035
9.6.7.6. GCC Market Revenue, By Region, 2025-2035
9.6.8. South Africa
9.6.8.1. South Africa Market Revenue, By Type , 2025-2035 (USD Million)
9.6.8.2. South Africa Market Revenue, By Material, 2025-2035
9.6.8.3. South Africa Market Revenue, By Design, 2025-2035
9.6.8.4. South Africa Market Revenue, By Delivery, 2025-2035
9.6.8.5. South Africa Market Revenue, By Application, 2025-2035
9.6.8.6. South Africa Market Revenue, By Region, 2025-2035
9.6.9. Rest of Middle-East and Africa
9.6.9.1. Rest of Middle-East and Africa Market Revenue, By Type , 2025-2035 (USD Million)
9.6.9.2. Rest of Middle-East and Africa Market Revenue, By Material, 2025-2035
9.6.9.3. Rest of Middle-East and Africa Market Revenue, By Design, 2025-2035
9.6.9.4. Rest of Middle-East and Africa Market Revenue, By Delivery, 2025-2035
9.6.9.5. Rest of Middle-East and Africa Market Revenue, By Application, 2025-2035
9.6.9.6. Rest of Middle-East and Africa Market Revenue, By Region, 2025-2035
10. Company Profiles
10.1. Baxter International Inc.
10.1.1. Business Overview
10.1.2. Financial Performance
10.1.3. Product/Service Offerings
10.1.4. Strategies & recent developments
10.1.5. SWOT Analysis
10.2. Becton Dickinson
10.2.1. Business Overview
10.2.2. Financial Performance
10.2.3. Product/Service Offerings
10.2.4. Strategies & recent developments
10.2.5. SWOT Analysis
10.3. Biocon
10.3.1. Business Overview
10.3.2. Financial Performance
10.3.3. Product/Service Offerings
10.3.4. Strategies & recent developments
10.3.5. SWOT Analysis
10.4. Cardinal Health
10.4.1. Business Overview
10.4.2. Financial Performance
10.4.3. Product/Service Offerings
10.4.4. Strategies & recent developments
10.4.5. SWOT Analysis
10.5. Catalent
10.5.1. Business Overview
10.5.2. Financial Performance
10.5.3. Product/Service Offerings
10.5.4. Strategies & recent developments
10.5.5. SWOT Analysis
10.6. Datwyler Holding Inc.
10.6.1. Business Overview
10.6.2. Financial Performance
10.6.3. Product/Service Offerings
10.6.4. Strategies & recent developments
10.6.5. SWOT Analysis
10.7. Debiotech S.A
10.7.1. Business Overview
10.7.2. Financial Performance
10.7.3. Product/Service Offerings
10.7.4. Strategies & recent developments
10.7.5. SWOT Analysis
10.8. Elcam Medical
10.8.1. Business Overview
10.8.2. Financial Performance
10.8.3. Product/Service Offerings
10.8.4. Strategies & recent developments
10.8.5. SWOT Analysis
10.9. Fresenius Kabi AG
10.9.1. Business Overview
10.9.2. Financial Performance
10.9.3. Product/Service Offerings
10.9.4. Strategies & recent developments
10.9.5. SWOT Analysis
10.10. Gerresheimer
10.10.1. Business Overview
10.10.2. Financial Performance
10.10.3. Product/Service Offerings
10.10.4. Strategies & recent developments
10.10.5. SWOT Analysis
10.11. Jiangsu Micsafe Medical Technology Co., Ltd
10.11.1. Business Overview
10.11.2. Financial Performance
10.11.3. Product/Service Offerings
10.11.4. Strategies & recent developments
10.11.5. SWOT Analysis
10.12. MedXL Inc
10.12.1. Business Overview
10.12.2. Financial Performance
10.12.3. Product/Service Offerings
10.12.4. Strategies & recent developments
10.12.5. SWOT Analysis

10.13. Nipro Corporation

10.13.1. Business Overview
10.13.2. Financial Performance
10.13.3. Product/Service Offerings
10.13.4. Strategies & recent developments
10.13.5. SWOT Analysis

10.14. Owen Mumford Ltd

10.14.1. Business Overview
10.14.2. Financial Performance
10.14.3. Product/Service Offerings
10.14.4. Strategies & recent developments
10.14.5. SWOT Analysis

10.15. Scandinavian Health Limited (SHL) Group

10.15.1. Business Overview
10.15.2. Financial Performance
10.15.3. Product/Service Offerings
10.15.4. Strategies & recent developments
10.15.5. SWOT Analysis

10.16. Schott

10.16.1. Business Overview
10.16.2. Financial Performance
10.16.3. Product/Service Offerings
10.16.4. Strategies & recent developments
10.16.5. SWOT Analysis
10.17. Stevanato Group
10.17.1. Business Overview
10.17.2. Financial Performance
10.17.3. Product/Service Offerings
10.17.4. Strategies & recent developments
10.17.5. SWOT Analysis
10.18. Terumo Corporation
10.18.1. Business Overview
10.18.2. Financial Performance
10.18.3. Product/Service Offerings
10.18.4. Strategies & recent developments
10.18.5. SWOT Analysis
10.19. Unilife Corporation
10.19.1. Business Overview
10.19.2. Financial Performance
10.19.3. Product/Service Offerings
10.19.4. Strategies & recent developments
10.19.5. SWOT Analysis
10.20. Vetter Pharma
10.20.1. Business Overview
10.20.2. Financial Performance
10.20.3. Product/Service Offerings
10.20.4. Strategies & recent developments
10.20.5. SWOT Analysis

ページTOPに戻る

List of Tables/Graphs

Tables
TABLE 1. GLOBAL PRE-FILLING SYRINGES MARKET VALUE, BY MATERIAL TYPE, 2022-2028 (USD BILLION)
TABLE 2. GLOBAL PRE-FILLING SYRINGES MARKET VALUE FOR ACTIVATED CARBON, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 3. GLOBAL PRE-FILLING SYRINGES MARKET VALUE FOR CARBON DERIVATIVES, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 4. GLOBAL PRE-FILLING SYRINGES MARKET VALUE FOR METAL OXIDES, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 5. GLOBAL PRE-FILLING SYRINGES MARKET VALUE FOR CONDUCTIVE POLYMERS, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 6. GLOBAL PRE-FILLING SYRINGES MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 7. GLOBAL PRE-FILLING SYRINGES MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 8. GLOBAL PRE-FILLING SYRINGES MARKET VALUE FOR CONSUMER ELECTRONICS, 2022-2028 (USD BILLION)
TABLE 9. GLOBAL PRE-FILLING SYRINGES MARKET VALUE FOR INDUSTRIAL, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 10. GLOBAL PRE-FILLING SYRINGES MARKET VALUE FOR TRANSPORTATION, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 11. GLOBAL PRE-FILLING SYRINGES MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 12. NORTH AMERICA PRE-FILLING SYRINGES MARKET VALUE, BY COUNTRY, 2022-2028 (USD BILLION)
TABLE 13. NORTH AMERICA PRE-FILLING SYRINGES MARKET VALUE, BY MATERIAL TYPE, 2022-2028 (USD BILLION)
TABLE 14. NORTH AMERICA PRE-FILLING SYRINGES MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 15. U.S PRE-FILLING SYRINGES MARKET VALUE, BY MATERIAL TYPE, 2022-2028 (USD BILLION)
TABLE 16. U.S PRE-FILLING SYRINGES MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 17. CANADA PRE-FILLING SYRINGES MARKET VALUE, BY MATERIAL TYPE, 2022-2028 (USD BILLION)
TABLE 18. CANADA PRE-FILLING SYRINGES MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 19. EUROPE PRE-FILLING SYRINGES MARKET VALUE, BY COUNTRY, 2022-2028 (USD BILLION)
TABLE 20. EUROPE PRE-FILLING SYRINGES MARKET VALUE, BY MATERIAL TYPE, 2022-2028 (USD BILLION)
TABLE 21. EUROPE PRE-FILLING SYRINGES MARKET VALUE, APPLICATION, 2022-2028 (USD BILLION)
TABLE 22. GERMANY PRE-FILLING SYRINGES MARKET VALUE, BY MATERIAL TYPE, 2022-2028 (USD BILLION)
TABLE 23. GERMANY PRE-FILLING SYRINGES MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 24. U.K PRE-FILLING SYRINGES MARKET VALUE, BY MATERIAL TYPE, 2022-2028 (USD BILLION)
TABLE 25. U.K PRE-FILLING SYRINGES MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 26. FRANCE PRE-FILLING SYRINGES MARKET VALUE, BY MATERIAL TYPE, 2022-2028 (USD BILLION)
TABLE 27. FRANCE PRE-FILLING SYRINGES MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 28. ITALY PRE-FILLING SYRINGES MARKET VALUE, BY MATERIAL TYPE, 2022-2028 (USD BILLION)
TABLE 29. ITALY PRE-FILLING SYRINGES MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 30. SPAIN PRE-FILLING SYRINGES MARKET VALUE, BY MATERIAL TYPE, 2022-2028 (USD BILLION)
TABLE 31. SPAIN PRE-FILLING SYRINGES MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 32. ROE PRE-FILLING SYRINGES MARKET VALUE, BY MATERIAL TYPE, 2022-2028 (USD BILLION)
TABLE 33. ROE PRE-FILLING SYRINGES MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 34. ASIA PACIFC PRE-FILLING SYRINGES MARKET VALUE, BY COUNTRY, 2022-2028 (USD BILLION)
TABLE 35. ASIA PACIFC PRE-FILLING SYRINGES MARKET VALUE, BY MATERIAL TYPE, 2022-2028 (USD BILLION)
TABLE 36. ASIA PACIFC PRE-FILLING SYRINGES MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 37. CHINA PRE-FILLING SYRINGES MARKET VALUE, BY MATERIAL TYPE, 2022-2028 (USD BILLION)
TABLE 38. CHINA PRE-FILLING SYRINGES MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 39. INDIA PRE-FILLING SYRINGES MARKET VALUE, BY MATERIAL TYPE, 2022-2028 (USD BILLION)
TABLE 40. INDIA PRE-FILLING SYRINGES MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 41. JAPAN PRE-FILLING SYRINGES MARKET VALUE, BY MATERIAL TYPE, 2022-2028 (USD BILLION)
TABLE 42. JAPAN PRE-FILLING SYRINGES MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 43. REST OF APAC PRE-FILLING SYRINGES MARKET VALUE, BY MATERIAL TYPE, 2022-2028 (USD BILLION)
TABLE 44. REST OF APAC PRE-FILLING SYRINGES MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 45. REST OF WORLD PRE-FILLING SYRINGES MARKET VALUE, BY MATERIAL TYPE, 2022-2028 (USD BILLION)
TABLE 46. REST OF WORLD PRE-FILLING SYRINGES MARKET VALUE, BY APPLICATION, 2022-2028 (USD BILLION)
TABLE 47. CABOT(NORIT): FINANCIALS
TABLE 48. CABOT(NORIT): PRODUCTS & SERVICES
TABLE 49. CABOT(NORIT): RECENT DEVELOPMENTS
TABLE 50. KURARY CO. LTD: FINANCIALS
TABLE 51. KURARY CO. LTD: PRODUCTS & SERVICES
TABLE 52. KURARY CO. LTD: RECENT DEVELOPMENTS
TABLE 53. BAYER MATERIALSCIENCE AG: FINANCIALS
TABLE 54. BAYER MATERIALSCIENCE AG: PRODUCTS & SERVICES
TABLE 55. BAYER MATERIALSCIENCE AG: RECENT DEVELOPMENTS
TABLE 56. CALGON CARBON CORPORATION: FINANCIALS
TABLE 57. CALGON CARBON CORPORATION: PRODUCTS & SERVICES
TABLE 58. CALGON CARBON CORPORATION: RECENT DEVELOPMENTS
TABLE 59. CARBON NT&F: FINANCIALS
TABLE 60. CARBON NT&F: PRODUCTS & SERVICES
TABLE 61. CARBON NT&F: RECENT DEVELOPMENTS
TABLE 62. SHENZHEN NTP: FINANCIALS
TABLE 63. SHENZHEN NTP: PRODUCTS & SERVICES
TABLE 64. SHENZHEN NTP: RECENT DEVELOPMENTS
TABLE 65. CECA SA: FINANCIALS
TABLE 66. CECA SA: PRODUCTS & SERVICES
TABLE 67. CECA SA: RECENT DEVELOPMENTS
TABLE 68. CNANO TECHNOLOGY: FINANCIALS
TABLE 69. CNANO TECHNOLOGY: PRODUCTS & SERVICES
TABLE 70. CNANO TECHNOLOGY: RECENT DEVELOPMENTS
TABLE 71. DONAU CHEMIE GROUP: FINANCIALS
TABLE 72. DONAU CHEMIE GROUP: PRODUCTS & SERVICES
TABLE 73. DONAU CHEMIE GROUP: RECENT DEVELOPMENTS
TABLE 74. SHOWA DENKO: FINANCIALS
TABLE 75. SHOWA DENKO: PRODUCTS & SERVICES
TABLE 76. SHOWA DENKO: RECENT DEVELOPMENTS